Announcement • Apr 30
MicroSalt plc Launches Microsalt Fibre Microsalt Plc announced the launch of Microsalt Fibre, extending its patented technology into a dual function solution that enables both sodium reduction and functional fibre within a single ingredient. Microsalt Fibre is a patented, dual action ingredient technology that combines Microsalt's established low sodium salt with functional fibre. Microsalt patented technology covers the use of a broad range of carriers and a consistent production process, meaning the same proven know-how and controls behind Microsalt are applied to Microsalt Fibre. The product enables manufacturers to address two key nutritional objectives simultaneously reducing sodium content and increasing fibre, while maintaining flavour, texture, and operational efficiency. This launch reflects a broader shift in the food industry, where reformulation is no longer focused on single nutrient reduction, but on delivering multiple nutritional improvements at the same time, without compromising product performance. According to Fortune Business Insights, the global dietary fibre market was valued at $9,600 million in 2025. The market is projected to grow from $10,600 million in 2026 to $22,000 million by 2034, exhibiting a CAGR of 9.63% during the forecast period. Additionally, as international demand grows for tighter regulation of sodium consumption, including the expansion of High Fat, Sugar and Salt regulations in the UK, the company believes that technology capable of both reducing sodium and improving product health profiles through increased fibre content positions Microsalt to further expand its reach and strengthen its market share. Microsalt Fibre has been formulated to support these evolving global requirements through a single-ingredient solution that can be deployed across multiple product applications. Microsalt Fibre was developed in response to growing demand for functional carriers to replace or enhance empty calorie carriers such as maltodextrin, driven by evolving consumer preferences and the rise of GLP-1-related nutritional gaps. Suitable for use across a range of food categories, including snacks, baked goods and prepared meals, the technology has been designed for seamless integration into existing manufacturing processes, enabling rapid deployment at industrial scale without requiring reformulation complexity or changes to established production systems. Microsalt enjoys tailwinds resulting from increased regulation and as regulatory frameworks evolve and front of pack labelling systems become more stringent, sodium reduction and fibre enhancement are emerging as two of the most immediate and actionable levers available to manufacturers. Microsalt is not only reducing sodium, but also enabling a new standard for practical, scalable food reformulation. New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Negative equity (-US$159k). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable next year (US$1.6m net loss next year). Revenue is less than US$5m (US$1.4m revenue). Market cap is less than US$100m (UK£30.0m market cap, or US$40.6m). Announcement • Dec 13
MicroSalt plc has completed a Follow-on Equity Offering in the amount of £0.22759 million. MicroSalt plc has completed a Follow-on Equity Offering in the amount of £0.22759 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 505,756
Price\Range: £0.45 
